SCHEMBL14083820

SCHEMBL14083820

COc1cc(C(=O)Nc2ccc(OCc3ccccc3)cc2)ccc1-c1ncccc1Cl

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 7/20 0.58
▸ KMT2A Q03164 7/20 0.58
▸ MAPT P10636 5/20 0.58
▸ KDM4E B2RXH2 2/20 0.56
▸ RAB9A P51151 5/20 0.54
▸ NPC1 O15118 4/20 0.54
▸ SMN1; SMN2 Q16637 2/20 0.54
▸ AURKB Q96GD4 1/20 0.51
▸ ALDH1A1 P00352 2/20 0.50
▸ CYP1A2 P05177 1/20 0.50
▸ CYP2C9 P11712 1/20 0.50
▸ CYP2C19 P33261 1/20 0.50
▸ CASP3 P42574 1/20 0.49
▸ SENP7 Q9BQF6 1/20 0.49
▸ LMNA P02545 3/20 0.48
▸ SCD O00767 1/20 0.48
▸ RXFP1 Q9HBX9 2/20 0.48
▸ NR1H4 Q96RI1 1/20 0.48
▸ ALOX12 P18054 1/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14083840 0.89 NPC1 (0.56) MEN1KMT2AMAPTKDM4ERAB9A
SCHEMBL14083730 0.88 AURKB (0.55) MEN1KMT2AMAPTKDM4ERAB9A
SCHEMBL14083729 0.88 AURKB (0.57) MEN1KMT2AMAPTRAB9ANPC1
SCHEMBL14083699 0.88 RAB9A (0.55) MEN1KMT2AMAPTRAB9ANPC1
SCHEMBL14083833 0.87 MAPT (0.54) MEN1KMT2AMAPTKDM4ERAB9A
SCHEMBL14083835 0.85 AURKB (0.56) MEN1KMT2ARAB9ANPC1SMN1; SMN2
SCHEMBL14083841 0.84 AURKB (0.55) MEN1KMT2AMAPTKDM4EAURKB
SCHEMBL14083800 0.84 NPC1 (0.64) MEN1KMT2AMAPTRAB9ANPC1
SCHEMBL14083862 0.83 RAB9A (0.65) MEN1KMT2ARAB9ANPC1SMN1; SMN2
SCHEMBL14083731 0.83 AURKB (0.54) MEN1KMT2AKDM4ERAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof KELLY MICHAEL G 2008-08-21 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed
US-7338950-B2 Amide compounds as ion channel ligands and uses thereof RENOVIS, INC. (US) 2008-03-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200524-A1 Amide compounds as ion channel ligands and uses thereof TRPV1, TRPA1, TRPV2 MEN1 4218/4885KMT2A 4272/4885MAPT 2822/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback